Your browser doesn't support javascript.
loading
The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking.
Harrison, Angela R; David, Cassandra T; Rawlinson, Stephen M; Moseley, Gregory W.
Affiliation
  • Harrison AR; Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • David CT; Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Rawlinson SM; Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Moseley GW; Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Viruses ; 13(8)2021 08 19.
Article in En | MEDLINE | ID: mdl-34452514
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Proteins / Interferon Type I / Cell Nucleus / Hemorrhagic Fever, Ebola / Cytoplasm / Ebolavirus Limits: Humans Language: En Journal: Viruses Year: 2021 Document type: Article Affiliation country: Australia Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Proteins / Interferon Type I / Cell Nucleus / Hemorrhagic Fever, Ebola / Cytoplasm / Ebolavirus Limits: Humans Language: En Journal: Viruses Year: 2021 Document type: Article Affiliation country: Australia Country of publication: Suiza